Driehaus Capital Management LLC Avrobio, Inc. Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$12.19 - $22.96 $3.01 Million - $5.68 Million	-247,248 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $2.49 Million - $6.73 Million	247,248 New	247,248 $3.85 Million
Q1 2019 May 15, 2019	SELL	$12.46 - $22.05 $1.79 Million - $3.17 Million	-143,762 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$15.43 - $32.7 $1.34 Million - $2.85 Million	-87,071 Reduced 37.72%	143,762 $2.39 Million
Q3 2018 Nov 14, 2018	SELL	$26.95 - $52.7 $1.51 Million - $2.96 Million	-56,124 Reduced 19.56%	230,833 $12 Million
Q2 2018 Aug 14, 2018	BUY	$28.08 - $31.2 $8.06 Million - $8.95 Million	286,957 New	286,957 $8.2 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.